Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity

Quan Zheng(Shanghai Jiao Tong University), Christopher Heeschen(Shanghai Jiao Tong University)
Journal of Experimental & Clinical Cancer Research
November 28, 2023
Cited by 16


Related Papers